Skip to main content
Log in

Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Matrix metalloproteinase 2 (MMP-2) facilitates tumor growth and metastasis in colon cancer. Although tumor cells may produce MMP-2, stromal cells, such as macrophages and fibroblasts, contribute significantly to MMP-2 synthesis in human tumors. We characterized four human colon cancer cell lines with differing biological behavior for MMP-2 expression. While the parent tumors from which the cell lines were derived all expressed MMP-2 mRNA, MMP-2 transcripts were detected in only one cell line, TF-17C, which is nontumorigenic in a nude mouse tumor model. TF-43C, which is tumorigenic and metastatic in the same tumor model, did not produce MMP-2, yet the tumors which arose from it after injection into nude mice did contain MMP-2 mRNA, suggesting a contribution from stromal cells. Co-culturing TF-43C with fibroblasts resulted in an increase in MMP-2 protein, whereas co-culturing with the nontumorigenic cell line TF-13Cm did not alter constitutive fibroblast MMP-2 secretion. Conditioned medium from TF-43C cells also stimulated fibroblast MMP-2 production. These data suggest that a soluble factor from TF-43C cells can stimulate fibroblast MMP-2 production and support the hypothesis that colon cancer cell interactions with stromal fibroblasts may be important determinants of tumor behavior in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991; 51(18 Suppl): 5054s–5059s.

    Google Scholar 

  2. Daneker GW, Jr., Mercurio AM, Guerra L, et al. Laminin expression in colorectal carcinomas varying in degree of differentiation. Arch Surg 1987; 122(12): 1470–4.

    Google Scholar 

  3. Forster SJ, Talbot IC, Clayton DG et al. Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance. Int J Cancer 1986; 37(6): 813–7.

    Google Scholar 

  4. Barsky SH, Siegal GP, Jannotta F et al. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983; 49(2): 140–7.

    Google Scholar 

  5. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14(7): 455–63.

    Google Scholar 

  6. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995; 7(5): 728–35.

    Google Scholar 

  7. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89(17): 1260–70.

    Google Scholar 

  8. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol 1996; 7(3): 147–54.

    Google Scholar 

  9. Stetler-Stevenson WG, Corcoran ML. Tumor angiogenesis: functional similarities with tumor invasion. EXS 1997; 79: 413–8.

    Google Scholar 

  10. Ishikawa T, Ichikawa Y, Mitsuhashi M, et al. Matrilysin is associated with progression of colorectal tumor. Cancer Lett 1996; 107(1): 5–10.

    Google Scholar 

  11. Murray GI, Duncan ME, O'Neil P, Melvin WT et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996; 2(4): 461–2.

    Google Scholar 

  12. Zeng ZS, Huang Y, Cohen AM et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996; 14(12): 3133–40.

    Google Scholar 

  13. Morikawa K, Walker SM, Nakajima M, et al. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988; 48(23): 6863–71.

    Google Scholar 

  14. Shah V, Kumar S, Zirvi KA. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase. In Vivo 1994; 8(3): 321–6.

    Google Scholar 

  15. Emmert-Buck M, Roth M, Zhuang Z, et al. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 1994; 145(6): 1285–90.

    Google Scholar 

  16. Liabakk NB, Talbot I, Smith RA, et al. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996; 56(1): 190–6.

    Google Scholar 

  17. Murashige M, Miyahara M, Shiraishi N et al. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol 1996; 26(5): 303–9.

    Google Scholar 

  18. Levy AT, Cioce V, Sobel ME, et al. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991; 51(1): 439–44.

    Google Scholar 

  19. Tomita T, Iwata K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 1996; 39(11): 1255–64.

    Google Scholar 

  20. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2mRNAs in colorectal neoplasia. Am J Pathol 1992; 141(2): 389–96.

    Google Scholar 

  21. Pyke C, Ralfkiaer E, Tryggvason K, et al. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993; 142(2): 359–65.

    Google Scholar 

  22. Grigioni WF, D'Errico A, Fiorentino M et al. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagn Mol Pathol 1994; 3(3): 163–9.

    Google Scholar 

  23. Ohtani H, Motohashi H, Sato H et al. Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int J Cancer 1996; 68(5): 565–70.

    Google Scholar 

  24. Swallow CJ, Murray MP, Guillem JG. Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes. Clin Exp Metastasis 1996; 14(1): 3–11.

    Google Scholar 

  25. Farrell TM, Pettengill OS, Longnecker DS, et al. In vitro growth of colon tumors predicts metastatic potential. Gastroenterology, in press 1998.

  26. Riley HD, Macnab J, Farrell TJ et al. The expression of acylphosphatase is associated with the metastatic phenotype in human colorectal tumors. Carcinogenesis 1997; 18(12): 2453–5.

    Google Scholar 

  27. Onisto M, Garbisa S, Caenazzo C, et al. Reverse transcriptionpolymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diagn Mol Pathol 1993; 2(2): 74–80.

    Google Scholar 

  28. Huhtala P, Chow LT, Tryggvason K. Structure of the human type IV collagenase gene. J Biol Chem 1990; 265(19): 11077–82.

    Google Scholar 

  29. Grandchamp B, De Verneuil H, Beaumont C, et al. Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. Eur J Biochem 1987; 162(1): 105–10.

    Google Scholar 

  30. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994; 218(2): 325–9.

    Google Scholar 

  31. An Z, Wang X, Willmott N, et al. Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Metastasis 1997; 15(2): 184–95.

    Google Scholar 

  32. Watson SA, Morris TM, Parsons SL, et al. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model. Br J Cancer 1996; 74(9): 1354–8.

    Google Scholar 

  33. Denis LJ, Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest New Drugs 1997; 15(3): 175–85.

    Google Scholar 

  34. Okada A, Bellocq JP, Rouyer N, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A 1995; 92(7): 2730–4.

    Google Scholar 

  35. Loizidou MC, Carpenter R, Laurie H, et al. Growth enhancement of implanted human colorectal cancer cells by the addition of fibroblasts in vivo. Br J Surg 1996; 83(1): 24–8.

    Google Scholar 

  36. Kataoka H, Meng JY, Uchino H, et al. Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs. Oncol Res 1997; 9(3): 101–9.

    Google Scholar 

  37. Noel A, Hajitou A, L'Hoir C, et al. Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts. Int J Cancer 1998; 76(2): 267–73.

    Google Scholar 

  38. Westerlund A, Hujanen E, Puistola U, et al. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2). Gynecol Oncol 1997; 67(1): 76–82.

    Google Scholar 

  39. Miyagi E, Yasumitsu H, Hirahara F, et al. Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice. Clin Exp Metastasis 1995; 13(2): 89–96.

    Google Scholar 

  40. Stetler-Stevenson W, Krutzsch H, Liotta L. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 1989; 264(29): 17374–8.

    Google Scholar 

  41. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370(6484): 61–5.

    Google Scholar 

  42. Migita K, Eguchi K, Kawabe Y, et al. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 1996; 89(4): 553–7.

    Google Scholar 

  43. Salo T, Makela M, Kylmaniemi M. Autio-Harmainen H, Larjava H. Expression of matrix metalloproteinase-2 and-9 during early human wound healing. Lab Invest 1994; 70(2): 176–82.

    Google Scholar 

  44. Cullen B, Silcock D, Brown LJ, et al. The differential regulation and secretion of proteinases from fetal and neonatal fibroblasts by growth factors. Int J Biochem Cell Biol 1997; 29(1): 241–50.

    Google Scholar 

  45. Hecker-Kia A, Kolkenbrock H, Orgel D, et al. Substance P induces the secretion of gelatinase A from human synovial fibroblasts. Eur J Clin Chem Clin Biochem 1997; 35(9): 655–60.

    Google Scholar 

  46. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993; 53(4): 288–95.

    Google Scholar 

  47. Kataoka H, DeCastro R, Zucker S, et al. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase. Cancer Res 1993; 53(13): 3154–8.

    Google Scholar 

  48. Hsu S, Huang F, Friedman E. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J Cell Physiol 1995; 165(2): 239–45.

    Google Scholar 

  49. Huang F, Newman E, Theodorescu D, et al. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Cell Growth Differ 1995; 6(12): 1635–42.

    Google Scholar 

  50. Lamoreaux WJ, Fitzgerald ME, Reiner A, et al. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 1998; 55(1): 29–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ornstein, D.L., MacNab, J. & Cohn, K.H. Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer. Clin Exp Metastasis 17, 205–212 (1999). https://doi.org/10.1023/A:1006562818088

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006562818088

Navigation